纳米规模的抗癌药物通过一种基于的金属有机框架载体提供
Prasenjit Das1, Gouri Chakraborty1, Jasreen Kaur2
1Department of Chemical Sciences, Indian Institute of Science Education and Research Mohali, Sector 81, Manauli P.O., S.A.S. Nagar Mohali, Punjab, 140306, India.
Small (Weinheim an der Bergstrasse, Germany)
|February 7, 2025
概括
这项研究强调了以为基础的金属有机框架 (MOF) 作为有效的纳米药物载体. 它展示了用于癌症治疗的高药载荷和持续释放,在药物递送系统 (DDS) 中显示出前景.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 金属有机框架 (MOF) 是先进的多孔材料,在生物医学应用中具有显著的潜力.
- 它们的高表面积,可调节的孔径大小和功能使它们成为药物递送系统 (DDS) 的理想候选者.
研究的目的:
- 为了研究一种特定的基于的MOF (Zn-MOF) 作为纳米药物载体的有效性.
- 为了评估其在加载和释放两个模型药物的性能:5-甲和calcein.
- 评估Zn-MOF对人类乳腺癌细胞的抗癌活性.
主要方法:
- 合成和Zn-MOF的表征.
- 使用5-甲和素进行的药物加载研究.
- 通过光谱和显微镜技术监测的体外药物释放概况.
- 对抗MCF-7细胞的抗癌活性的评估.
主要成果:
- 这种Zn-MOF表现出高效的纳米药物载体行为.
- 对于5-甲和素,都实现了高药载荷能力.
- 观察到缓慢和持续的药物释放特征.
- 含有药物的Zn-MOF对MCF-7细胞表现出显著的抗癌活性.
结论:
- 开发的Zn-MOF显示出作为持续药物输送的纳米药物载体的绝佳潜力.
- 它在输送化疗剂中的有效性及其抗癌性质需要进一步研究乳腺癌治疗.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


